In its fight against COVID-19, Capital Energy joins the OxyVita Emergency Ventilator initiative, to develop a low-cost respirator

OxyVita Emergency Ventilator is a sustainable development project led by Ennomotive (prototype development and coordination) in which the companies Vithas and its Foundation (approval), McFly Technologies (industrialisation) and Iyntia (pre-series financing) are taking part.

Other institutions and companies are also collaborating, such as Universidad Francisco de Vitoria, Universidad Católica de Valencia, Medical Simulator, ICAI Engineers’ Foundation for development, Capital Energy and Hospital Militar Gómez Ulla, where testing will be carried out with a porcine model in its Animal Experimental Surgery service.

The initiative arose from an international tender called on 18 March by ennomotive.com and more than 50 solutions were submitted. The new OxyVita ventilator, based on pressure control with volume measurement, was designed by Frede Jensen, a British engineer with more than 30 years’ experience developing medical devices.

The OxyVita validation pre-series will be manufactured in Toledo and will initially be earmarked to ensure stock in Spanish hospitals. Given its small price and size, its compact design and easy maintenance, OxyVita will be available for all countries that are in an emergency situation, field hospitals in countries with weaker economies and armies in any part of the world. One of the aims of this sustainable development project is its internationalisation and the possibility of manufacturing the ventilator anywhere in the world, duty-free.